Legence Corp. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: LGN · Form: 8-K · Filed: Sep 15, 2025 · CIK: 2052568
| Field | Detail |
|---|---|
| Company | Legence CORP. (LGN) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.01, $150,000, $28.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: definitive-agreement, equity-sale, officer-changes, corporate-governance
TL;DR
Legence Corp. 8-K: Material agreements, equity sales, and exec changes filed 9/15/25.
AI Summary
On September 15, 2025, Legence Corp. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement, unregistered sales of equity securities, and modifications to security holder rights. The report also covers the departure of directors or officers, election of new directors, appointment of officers, and changes to compensatory arrangements. Additionally, amendments to the company's articles of incorporation or bylaws and a change in fiscal year were noted, alongside other events and financial statements.
Why It Matters
This 8-K filing indicates significant corporate actions at Legence Corp., including potential new agreements, equity transactions, and changes in leadership or governance, which could impact the company's strategic direction and shareholder value.
Risk Assessment
Risk Level: medium — The filing involves multiple material events including definitive agreements, unregistered equity sales, and changes in officers/directors, suggesting potential shifts in the company's structure and financial dealings.
Key Players & Entities
- Legence Corp. (company) — Registrant
- September 15, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Legence Corp.?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
Were there any unregistered sales of equity securities by Legence Corp.?
Yes, the 8-K filing indicates unregistered sales of equity securities by Legence Corp.
Did Legence Corp. experience any changes in its board of directors or executive officers?
Yes, the filing reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
Are there any amendments to Legence Corp.'s articles of incorporation or bylaws?
Yes, the filing indicates amendments to the articles of incorporation or bylaws.
Has Legence Corp. changed its fiscal year?
Yes, the filing explicitly lists 'Change in Fiscal Year' as an item of disclosure.
Filing Stats: 2,450 words · 10 min read · ~8 pages · Grade level 11 · Accepted 2025-09-15 17:13:07
Key Financial Figures
- $0.01 — stered Class A common stock, par value $0.01 per share LGN The Nasdaq Stock Mark
- $150,000 — A Common Stock valued at approximately $150,000 as of the grant date that are subject t
- $28.00 — mon Stock at a public offering price of $28.00 per share. Pursuant to the Underwriting
Filing Documents
- d942093d8k.htm (8-K) — 51KB
- d942093dex11.htm (EX-1.1) — 237KB
- d942093dex31.htm (EX-3.1) — 55KB
- d942093dex32.htm (EX-3.2) — 122KB
- d942093dex41.htm (EX-4.1) — 122KB
- d942093dex101.htm (EX-10.1) — 306KB
- d942093dex102.htm (EX-10.2) — 194KB
- d942093dex103.htm (EX-10.3) — 50KB
- d942093dex104.htm (EX-10.4) — 133KB
- d942093dex105.htm (EX-10.5) — 47KB
- d942093dex106.htm (EX-10.6) — 44KB
- d942093dex107.htm (EX-10.7) — 38KB
- d942093dex108.htm (EX-10.8) — 30KB
- 0001193125-25-203770.txt ( ) — 1900KB
- lgn-20250915.xsd (EX-101.SCH) — 2KB
- lgn-20250915_lab.xml (EX-101.LAB) — 18KB
- lgn-20250915_pre.xml (EX-101.PRE) — 11KB
- d942093d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated September 11, 2025, by and among Legence Corp., Legence Holdings LLC and Goldman Sachs & Co. LLC and Jefferies LLC, on behalf of themselves and each of the other underwriters named in Schedule I thereto. 3.1 Amended and Restated Certificate of Incorporation of Legence Corp. 3.2 Amended and Restated Bylaws of Legence Corp. 4.1 Registration Rights Agreement, dated as of September 15, 2025, by and among Legence Corp. and each of the other signatories from time to time party thereto. 10.1 Amended and Restated Limited Liability Company Agreement of Legence Holdings LLC, dated as of September 11, 2025, by and among Legence Corp. and the other signatories parties thereto. 10.2 Tax Receivable Agreement, dated as of September 11, 2025, by and among Legence Corp. and the TRA Parties (as defined in the Tax Receivable Agreement). 10.3 Exchange Agreement, dated September 11, 2025, by and among Legence Corp. and each of the other signatories from time to time party thereto. 10.4 Legence Corp. 2025 Omnibus Incentive Plan. 10.5 Form of Stock Option Grant Notice and Award Agreement. 10.6 Form of RSU Grant Notice and Award Agreement. 10.7 Form of Non-Employee Director Restricted Stock Unit Grant Notice and Award Agreement. 10.8 Amendment No. 10 to the Credit Agreement, dated as of September 8, 2025, by and among Legence Intermediate LLC, Legence Holdings LLC, the guarantors party thereto and Jefferies Finance LLC. 10.9 Form of Indemnification Agreement (incorporated by reference to Exhibit 10.11 to the Company's Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 15, 2025). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LEGENCE CORP. Dated: September 15, 2025 By: /s/ Stephen Butz Name: Stephen Butz Title: Chief Financial Officer